The Role of Business Development in Changing Global TimesThursday 28th & Friday 29th September 2017

Event Highlights

• Welcome Networking Reception

• NEW Partnering System to Arrange Your Own Private Meeting Schedule

• Specific Private Meeting Area

• 6 Presentation Sessions, including OTC, Digital Technology and IP & Market Access

• Networking Reception and Gala Dinner at Casino de Madrid

• Access to Copies of Authorised Presentation Post-Event

• Opportunity to Network with BD Colleagues from Across Europe

www.plg-group.comMADRID

XIII International PharmaLicensing Symposium

XIII IPLS, Madrid 27th - 29th September 2017

‘The Role of Business Development in Changing Global Times’

Proposed Programme

www.plg-group.com

Wednesday, 27th September

15.00 - 18.00 Pre-Arranged One-to-One Meetings

18.00 - 19.30 Welcome Drinks Reception

Thursday, 28th September

09.00 - 09.30 Registration

SESSION 1 External Factors Impacting the Pharmaceutical Industry

09.30 - 09.45

Introduction & Keynote Presentation Juan López-Belmonte, Vice President, Farmaindustria & CEO, Laboratorios Rovi Speaking from both an industry and business perspective, Juan López-Belmonte will be setting the scene identfying the key challenges emerging from the current political climate, with a focus on the economic and business implictaions for pharmaceutical deal making

09.45 - 10.15

Industry Drivers, Trends, Analysis and Forecasts Antonio Iervolino, Head of Forecasting, Evaluate Sharing their insightful data and industry analysis, Evaluate are back by popular demand to identify the key trends evident in deals quantifying the impact on pharma business from the changing macro deal conditions

10.15 - 11.00

Brexit - Impact on Pharmaceutical Industry? European View: Impact on Strategies & UK View: Situation Post Brexit European View - Sergio Napolitano, Legal, Trade and Public Affairs Director, Medicines for Europe UK View - Jo Pisani, Partner, UK Pharma and Lifesciences Consulting Leader, PwC Strategy& Capturing and reflecting on the latest in developments in the Brexit negotiations, our speakers will comment on the key issues from both sides in the negotiation providing the view from the European and UK perspectives

11.00 - 11.30 Break

SESSION 2 The Impact of Digital Technology

11.30 - 12.00

Case Study – Sanofi & Voluntis Pierre Leurent, Voluntis In March Sanofi and Voluntis announced the original 2011 alliance to provide an app for assessing basal insulin was expanded. Pierre Leurent will be commenting on key features of this successful deal

12.00 - 12.30

Technology Companies Stepping into Digital Technologies Néstor Sanchez, Digital Transformation Manager, Indra With a wealth of experience in the development of healthcare information systems, Indra will review the impact of the transformations offered by digital technologies

12.30 - 13.00

Impact of General Data Protection Regulation (GDPR) Christoph Balduck, Managing Partner, Data Trust Associates This presentation will help healthcare companies to identify what challenges companies are facing in relation to privacy and data management strategies and way forward, including recommendations and best practices.

XIII IPLS, Madrid 27th - 29th September 2017

‘The Role of Business Development in Changing Global Times’

Proposed Programme

www.plg-group.com

13.00 - 14.00 Lunch

SESSION 3 The Role of Business Development

14.00 - 16.00

Panel Discussion - Business Development and Alliance Management Good Partnering Practices (GPP) conceived under the leadership of Swiss HLG Chair – Anthony A. Hörning, Strategic Transactions Advisory How do BD leaders see the impact of Good Partnering Practices in their organisations? Panel Laurence de Schoulepnikoff, Head of Strategy, Transaction and Legal Jörg Mayer, Director Business Development Europe, LTS Lohmann Henning Mennenöh, Weitnauer Advokaten

16.00 - 17.30 Pre-Arranged One-to-One meetings

19.00 - 22.30 Gala Dinner

XIII IPLS, Madrid 27th - 29th September 2017

‘The Role of Business Development in Changing Global Times’

Proposed Programme

www.plg-group.com

Friday, 29th September

SESSION 4 The Increasing Importance of the OTC and Other Business Areas

09.00 - 09.30 Case Study: Nestlé Health Science - Where Nutrition becomes Therapy Kim Bill, Vice President, Global Business Development & Licensing, Nestlé Health Science Identifying new business opportunities for growth in consumer healthcare markets

09.30 - 10.00

Emerging Trends in OTC & Why Big Pharma Should Play There Nicholas Hall, Chairman & CEO, Nicholas Hall Group of Companies Nicholas Hall will focus on the key opportunities arising in the OTC arena and the role major pharma play

10.00 - 10.30

Strategy Options for OTC in Emerging Markets and How to Enter the Best Markets Reiner Christensen, CEO and Co-Founder, Chameleon Pharma Consulting Group Reiner will give his insights on the OTC sector and how pharma companies can enter countries providing the best value

10.30 - 11.00 Break

SESSION 5 Risk or Opportunity? IP & Market Access

11.00 - 11.30 IP Management/Protection Livia Villa, European Patent Attorney, ADV IP Livia Villa will review the latest developments in IP in Europe including updates on SPC’s

11.30 - 12.00

Market Access – European Trends Professor Mondher Toumi, CEO, Creativ-Ceutical Critical to successful BD, Professor Toumi will consider recent decisions and issues arising in securing prices and gaining effective market access in Europe

12.00 - 12.30 Break

SESSION 6 Financial Evaluation & Business Models

12.30 - 13.00

From Valuation to Assets or From Assets to Valuation? Zaki Sellam, Managing Director, ESN Life Sciences This session will aim at not only using a simplified & elaborated rNPV model but also at understanding various asset features which are usually underestimated for a valuation

13.00 - 13.30

Business Models Paul Pay, Chief Business Development Officer, Norgine With business deals becoming increasingly creative, this presentation will review some successful example of innovative deal structures

13.30 Lunch and close

XIII International Pharma Licensing Symposium

NH Collection Eurobuilding Hotel, Madrid Thursday 28th & Friday 29th September 2017

To register for the XIII IPLS Meeting, please complete this form and return to NGA using one of the following methods:

Post NGA, Millennia House, Kingswood Park, Bonsor Drive, Kingswood, Surrey, KT20 6AY, UK Email acollins@ngaevents.co.uk Fax 00 44 (0)1737 379 802

Title Dr / Mr / Mrs / Ms Name

Job Title

Company

Address

Country

Telephone

Email (general contact and confirmation)

Email (used for delegate contact system)

Special Requirements (e.g. dietary, access requirements etc)

VAT Number (must be completed to confirm registration)

Price €875 Early Payment Discount Rate for payments received by 8th

May 2017

€1,025 Standard Rate for payments received on or after 9th

May 2017

Accommodation

Link to Discounted Accommodation Rates at NH Collection Eurobuilding Hotel, Madrid

Payment Payment by Cheque made payable to ‘NGA Ltd’ at the address above

Payment by Bank Transfer details will be sent out with booking confirmation

Payment by Credit Card MasterCard or Visa only, complete section below

Name of Card Holder

Credit Card Number

Expiry Date Security Code

Cardholder Signature Date

The NEW partnering system will be opened at the beginning of June, at which time you will be emailed a password to allow you access to your own profile on the partnering system, allowing you to edit your profile and arrange your own meeting schedule

Booking Terms & Conditions

Fee The attendance fee includes attendance at all sessions noted on the programme, all breaks, lunches and networking events. Please note that for reasons beyond the control of the organising committee it may prove necessary to change or amend the content or timing of the programme without prior warning. Meeting Registration – No Shows If having received a confirmed booking to the meeting, individuals who do not attend the meeting without prior notification to NGA in writing, will be liable for the full registration fee.

Meeting Cancellations Upon receiving your completed registration form, NGA will issue confirmation details and this booking will then be formally confirmed. Please note that all cancellations will be subject to a €50 administration charge. Delegate substitutions are welcome at any time. Cancellations received in writing after 21

st July 2017 will be subject to

100% cancellation charge unless the place can be re-sold to another delegate. In this case the €50 administration charge will apply. All cancellations must be sent to NGA in writing.